MX2007007183A - Aminas, combinacion de aminas y vanadio y sales de amina y vanadio para el tratamiento o prevencion de dislipidemia. - Google Patents
Aminas, combinacion de aminas y vanadio y sales de amina y vanadio para el tratamiento o prevencion de dislipidemia.Info
- Publication number
- MX2007007183A MX2007007183A MX2007007183A MX2007007183A MX2007007183A MX 2007007183 A MX2007007183 A MX 2007007183A MX 2007007183 A MX2007007183 A MX 2007007183A MX 2007007183 A MX2007007183 A MX 2007007183A MX 2007007183 A MX2007007183 A MX 2007007183A
- Authority
- MX
- Mexico
- Prior art keywords
- amines
- vanadium
- dyslipidemia
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporcionan combinaciones las cuales comprenden compuestos de vanadio (IV)(V) y aminas aceptables farmaceuticamente. Se proporcionan las combinaciones de las mismas para el tratamiento o prevencion de dislipidemia, diabetes, sindrome metabolico o enfermedades cardiovasculares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63682104P | 2004-12-16 | 2004-12-16 | |
PCT/EP2005/056888 WO2006064061A1 (en) | 2004-12-16 | 2005-12-16 | Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007007183A true MX2007007183A (es) | 2008-01-14 |
Family
ID=35788598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007007183A MX2007007183A (es) | 2004-12-16 | 2005-12-16 | Aminas, combinacion de aminas y vanadio y sales de amina y vanadio para el tratamiento o prevencion de dislipidemia. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060165814A1 (es) |
EP (1) | EP1827463A1 (es) |
JP (1) | JP2008524169A (es) |
CN (1) | CN101119736A (es) |
AU (1) | AU2005315565A1 (es) |
CA (1) | CA2591560A1 (es) |
MX (1) | MX2007007183A (es) |
WO (1) | WO2006064061A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112016013220B1 (pt) * | 2013-12-17 | 2021-08-24 | Simon Fraser University | Composições para atrair e/ou capturar insetos que se alimentam de sangue, usos das mesmas e método para atrair e/ou capturar insetos que se alimentam de sangue |
CN107029237B (zh) * | 2016-02-04 | 2021-06-25 | 康建胜 | 产热增强化合物增强去甲肾上腺素类化合物诱导褐色脂肪细胞产热的应用 |
CN106995828B (zh) * | 2017-02-04 | 2020-10-09 | 中国科学院成都生物研究所 | 利用喜树悬浮细胞生产n1-乙酰犬尿胺的方法 |
WO2021255228A1 (en) * | 2020-06-19 | 2021-12-23 | Société des Produits Nestlé S.A. | N-acetylspermidine to improve the gastrointestinal barrier |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4442305A (en) * | 1981-08-24 | 1984-04-10 | The United States Of America As Represented By The United States Department Of Energy | Polycatecholamide chelating agents |
US5300496A (en) * | 1991-09-30 | 1994-04-05 | The University Of British Columbia | Complexed vanadium for the treatment of diabetes mellitus |
SG49032A1 (en) * | 1993-11-15 | 1998-05-18 | Baker Med Res Inst | A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
JPH08245403A (ja) * | 1995-03-07 | 1996-09-24 | Baker Norton Pharmaceut Inc | インシュリン抵抗性症候群治療用組成物 |
WO2000016782A1 (en) * | 1998-09-18 | 2000-03-30 | The University Of British Columbia | Pharmaceutical compositions of vanadium biguanide complexes and their use |
US6808716B2 (en) * | 1999-01-08 | 2004-10-26 | Ruey J. Yu | N-acetylamino acids, related N-acetyl compounds and their topical use |
AU5094499A (en) * | 1999-07-08 | 2001-01-30 | Akesis Pharmaceuticals, Inc. | Combination of chromium and vanadium for glucose metabolism disorders |
WO2003097078A1 (en) * | 2002-05-15 | 2003-11-27 | Zhishin Inc. | Nutraceutical compositions comprising citrus alkaloids and method |
US20040224031A1 (en) * | 2003-05-06 | 2004-11-11 | Antonio Zorzano Olarte | Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus |
JP2008505161A (ja) * | 2004-07-02 | 2008-02-21 | ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ | 糖尿病の治療および/または予防用アリールアルキルアミンバナジウム(v)塩 |
EP1669079A1 (en) * | 2004-12-09 | 2006-06-14 | Genmedica Therapeutics | Composition of SSAO substrates and metal compounds of the Vla Vlb groups of the periodic table |
JP2006232679A (ja) * | 2005-02-22 | 2006-09-07 | Takaomi Aoki | バナジウムイオン含有高血圧及び高中性脂肪血症改善剤並びに高中性脂肪血症患者用血糖降下剤 |
-
2005
- 2005-12-16 EP EP05819142A patent/EP1827463A1/en not_active Withdrawn
- 2005-12-16 AU AU2005315565A patent/AU2005315565A1/en not_active Abandoned
- 2005-12-16 CN CNA2005800463996A patent/CN101119736A/zh active Pending
- 2005-12-16 MX MX2007007183A patent/MX2007007183A/es not_active Application Discontinuation
- 2005-12-16 WO PCT/EP2005/056888 patent/WO2006064061A1/en active Application Filing
- 2005-12-16 US US11/303,171 patent/US20060165814A1/en not_active Abandoned
- 2005-12-16 JP JP2007546080A patent/JP2008524169A/ja active Pending
- 2005-12-16 CA CA002591560A patent/CA2591560A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2005315565A1 (en) | 2006-06-22 |
JP2008524169A (ja) | 2008-07-10 |
US20060165814A1 (en) | 2006-07-27 |
CA2591560A1 (en) | 2006-06-22 |
WO2006064061A1 (en) | 2006-06-22 |
EP1827463A1 (en) | 2007-09-05 |
CN101119736A (zh) | 2008-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
WO2007003962A3 (en) | Gpcr agonists | |
NO20064792L (no) | Anvendelse av rotigotin til behandling og forbinding av Parkinsons pluss syndrom. | |
WO2005070390A3 (en) | Mitratapide oral solution | |
WO2008022024A3 (en) | Imidazole amines as inhibitors of beta-secretase | |
WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
IL219915A0 (en) | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases | |
IL180916A0 (en) | Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes | |
WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
EP1865967A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES | |
WO2007021839A3 (en) | Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors | |
EP1771188A4 (en) | METHOD AND COMPOSITIONS FOR TREATING ADIPOSITAS, INSULINED DISEASES AND HYPERCHOLESTERINEMIA | |
DK2026803T3 (da) | Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf | |
WO2007145835A3 (en) | Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity | |
WO2005044199A3 (en) | Combination of proton pump inhibitor and sleep aid | |
WO2008011487A3 (en) | L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain | |
MXPA06012143A (es) | Arilsulfonamidas y usos relacionados con las mismas. | |
WO2007109288A3 (en) | Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use | |
UA100527C2 (en) | Benzothiazoles as ghrelin receptor modulators | |
HRP20050075A2 (en) | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure | |
MY140538A (en) | Substituted n-acyl-2-aminothiazoles | |
WO2005112923A3 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
WO2006064228A3 (en) | Thiazolopyramidine compounds for the modulation of chemokine receptor activity | |
MX2007007183A (es) | Aminas, combinacion de aminas y vanadio y sales de amina y vanadio para el tratamiento o prevencion de dislipidemia. | |
WO2004052858A3 (en) | Inhibitors of monoamine uptake |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |